Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-058414
Filing Date
2008-03-17
Accepted
2008-03-17 11:47:12
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1228104
2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. dex231.htm EX-23.1 2219
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER. dex311.htm EX-31.1 7720
4 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER. dex312.htm EX-31.2 7776
5 SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER. dex321.htm EX-32.1 3907
6 SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER. dex322.htm EX-32.2 3949
7 GRAPHIC g54267graph_001.jpg GRAPHIC 53623
8 GRAPHIC g54267graph_002.jpg GRAPHIC 56666
  Complete submission text file 0001193125-08-058414.txt   1407325
Mailing Address TWO CORPORATE DR SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DR SOUTH SAN FRANCISCO CA 94080 650-266-1400
RENOVIS INC (Filer) CIK: 0001118361 (see all company filings)

EIN.: 943353740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50564 | Film No.: 08691696
SIC: 2834 Pharmaceutical Preparations